An infant is diagnosed with neonatal<unk>  if maternal antibodies, anti-Ro/SSA, anti-La/SSB, or less commonly anti-ribonucleoprotein, are present and if any of the clinical manifestations are present without any other explanation. Screening Screening includes testing for maternal antibodies and evaluating for heart block in utero. Universal screening is not recommended. Screening is usually performed when there is a higher likelihood for neonatal<unk>  such as individuals who are more likely to have antibodies due to autoimmune diseases or individuals who have had prior pregnancies complicated with neonatal<unk> . If a fetus develops heart block, screening for maternal antibodies can be considered. Monitoring for heart block can be done using a fetal echocardiogram.
Neonatal lupus erythematosus
Transient bullous dermolysis of the newborn
Neonatal tetanus
Neonatal herpes simplex
Neonatal hepatitis
Neonatal toxic shock-like exanthematous disease
Michelin tire baby syndrome
Congenital syphilis